Stay updated on HSV529 Vaccine in HSV-2 Seropositive Adults Clinical Trial
Sign up to get notified when there's something new on the HSV529 Vaccine in HSV-2 Seropositive Adults Clinical Trial page.

Latest updates to the HSV529 Vaccine in HSV-2 Seropositive Adults Clinical Trial page
- Check5 days agoChange DetectedRevision on the page footer updated from v3.3.3 to v3.3.4, a minor metadata/version change. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedLocations section added with Washington as a study site, the previous 'Washington Locations' entry was removed, and the page footer shows Revision: v3.3.3.SummaryDifference0.3%

- Check55 days agoChange DetectedRevision history updated to v3.3.2 (replacing v3.2.0).SummaryDifference0.1%

- Check62 days agoChange DetectedThe page no longer displays the standard government funding/status notice banner, removing the operating-status message. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check76 days agoChange DetectedThe new screenshot shows a redesigned page layout and styling, while the underlying study details and content remain the same. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check105 days agoChange DetectedAdds a government-status notice and a new software version (v3.2.0); removes the old version tag (v3.1.0).SummaryDifference4%

Stay in the know with updates to HSV529 Vaccine in HSV-2 Seropositive Adults Clinical Trial
Enter your email address, and we'll notify you when there's something new on the HSV529 Vaccine in HSV-2 Seropositive Adults Clinical Trial page.